Akin Ajayi, MD, discloses the following financial relationships: Advisor - Avadel Pharmaceuticals, Jazz Pharmaceuticals; Consultant - Avadel Pharmaceuticals, Jazz Pharmaceuticals; Independent contractor - Avadel Pharmaceuticals, Jazz Pharmaceuticals, Takeda; Speaker - Avadel Pharmaceuticals, Jazz Pharmaceuticals, Harmony Pharmaceuticals
Nancy Foldvary-Schaefer, DO, discloses the following financial relationships: Consultant - Jazz; Researcher - Jazz, Takeda, Suven, Alkermes, Avadel, Harmony Biosciences, Vanda
Lois Krahn, MD, discloses the following financial relationships: Advisor - Avadel; Researcher - Takeda, Alkermes
Joyce Lee-Iannotti, MD, has disclosed no financial relationships.
Mitchell G. Miglis, MD, discloses the following financial relationships: Consultant – Jazz Pharmaceuticals 
David T. Plante, MD, PhD, discloses the following financial relationships: Advisor - Jazz Pharmaceuticals , Alkermes, Harmony Biosciences, Apnimed, Centessa, Takeda; Consultant - Jazz, Alkermes, Harmony Biosciences, Centessa, Takeda; Researcher - Harmony Biosciences, Alkermes
Chad M. Ruoff, MD, discloses the following financial relationships: Jazz Pharmaceuticals - investigator initiated trial, DUET IH advisory board, narcolepsy steering committee , expert working group meeting (all money to Mayo); Alkermes Orexin Global - Advisory Meeting
Logan D. Schneider, MD, discloses the following financial relationships: Advisor - Jazz Pharmaceuticals, Axsome, SleepDev; Consultant - Jazz Pharmaceuticals, Avadel, Axsome
Virend K. Somers, MD, PhD, discloses the following financial relationships: Advisory Board to Sleep Number Corp; Consultant - Jazz Pharmaceutical, Lilly, Axome, ApniMed, iRhythm, Mineralis; Researcher - Funding paid to Mayo Clinic from National Institutes of Health.
Funding paid to Mayo Clinic from Sleep Number Corp, Research equipment gifted to Mayo Clinic from Zoll and Medtronic
Robert Thomas, MD, discloses the following financial relationships:  Researcher - Jazz Pharmaceuticals; Royalties or patent beneficiary - Licensed patent for ECG/PPG spectrogram: sleep quality and sleep apnea. Licensed by Beth Israel Deaconess Medical Center to MyCardio, LLC
Michael J. Thorpy, MD, discloses the following financial relationships: Consultant - Axsome, Balance Therapeutics, Eisai Pharmaceuticals, Flamel/Avadel, Harmony Biosciences, Idorsia Pharmaceuticals, Jazz Pharmaceuticals, NLS Pharmaceuticals, Suven Life Sciences, Takeda Pharmaceutical, and XWPharma

Staff Disclosures
Dorothy Caputo, MA, BSN, RN, AKH Lead Nurse Planner/Reviewer: has disclosed no financial relationships.
Michele Bielarski, RN, Nurse Reviewer: has disclosed no financial relationships.
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer): has disclosed no financial relationships.
Patricia Brignoni, AKH Director of Operations/Reviewer: has disclosed no financial relationships.
AKH and Clinical CME Group, LLC, Staff and Planners have no financial relationships to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.